Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Q32 Bio (QTTB) EPS (Weighted Average and Diluted) (2021 - 2025)

Historic EPS (Weighted Average and Diluted) for Q32 Bio (QTTB) over the last 5 years, with Q3 2025 value amounting to -$0.6.

  • Q32 Bio's EPS (Weighted Average and Diluted) rose 5890.41% to -$0.6 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.26, marking a year-over-year increase of 9622.51%. This contributed to the annual value of -$0.01 for FY2024, which is 9999.57% up from last year.
  • As of Q3 2025, Q32 Bio's EPS (Weighted Average and Diluted) stood at -$0.6, which was up 5890.41% from -$0.78 recorded in Q2 2025.
  • Q32 Bio's 5-year EPS (Weighted Average and Diluted) high stood at $5.1 for Q4 2024, and its period low was -$77.15 during Q4 2023.
  • Its 5-year average for EPS (Weighted Average and Diluted) is -$8.55, with a median of -$0.61 in 2021.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first soared by 805000.0% in 2022, then crashed by 1275833.33% in 2023.
  • Quarter analysis of 5 years shows Q32 Bio's EPS (Weighted Average and Diluted) stood at -$0.61 in 2021, then grew by 1.23% to -$0.6 in 2022, then tumbled by 12758.33% to -$77.15 in 2023, then soared by 106.61% to $5.1 in 2024, then plummeted by 111.76% to -$0.6 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at -$0.6 for Q3 2025, versus -$0.78 for Q2 2025 and -$0.9 for Q1 2025.